Fortis Healthcare Board Defers Approving Financial Results Again
Fortis said its board has again deferred approval of quarterly and annual financial results.
Fortis Healthcare Ltd. today said its board has again deferred approval of quarterly and annual financial results for the period ended March 31, 2018, saying more time is needed to consider the aspects of outcome of an internal investigation on alleged financial irregularities.
The date for the approval of the said accounts will be June 25, the company said in a regulatory filing.
Explaining the reasons for the deferment, Fortis said the internal investigation conducted by Luthra & Luthra Law Offices, as initiated by the Audit and Risk Management Committee, has been completed and their report was made available on June 8. “The same was duly placed before the Audit and Risk Management Committee and the Board at their meetings held today,” the company said.
The report has been shared with the statutory auditors and is being submitted to SEBI and SFIO forthwith, it added.
"In light of the above, the completion of the audit and accounts will require additional time to consider the aspects of the report comprehensively in the financial accounts," Fortis said.
The company, however, did not share the details of findings of the report.
On May 30, the company had postponed board meeting scheduled to consider financial results for the fourth quarter and financial year ended March 31, 2018, to June 11. It had cited deliberations on the conclusions of the internal investigation on the alleged financial irregularities in the company as reason for the deferment.
The healthcare chain, which is currently in the process of finding a buyer, had appointed the law firm in March to investigate allegations of fund diversion from Fortis Healthcare by former promoters Singh brothers.
Markets regulator SEBI is also investigating the matter related to alleged lapses at Fortis Healthcare and Religare Enterprises. Apart from SEBI, the Serious Fraud Investigation Office has also initiated a probe into the alleged financial irregularities at the two companies.
The investigations were initiated by the agencies against the backdrop of reports that Fortis Healthcare promoters Malvinder Singh and Shivinder Singh took at least USD 78 million out of the company without any board approval about a year ago.
Shares of Fortis today closed at Rs 143.60 per scrip on BSE, down 1.68 percent from the previous close.